Design, formulation, in vitro, in vivo, and pharmacokinetic evaluation of nisoldipine-loaded self-nanoemulsifying drug delivery system
Source abstract
Abstract
The aim of the present work was to prepare and optimize the self-nanoemulsifying drug delivery system (SNEDDS) of poor aqueous soluble and less bioavailable nisoldipine to improve its solubility and bioavailability. The solubility of nisoldipine was assessed in various vehicles and ternary phase diagram was constructed to identify the efficient self-emulsifying region. The selected formulations were evaluated for self-emulsification time, droplet size analysis, and in vitro drug release profile. The optimized formulation ACP 19 had reduced particle size (118.3 ± 1.53 nm), when compared to PCT 08 (740 ± 1.16 nm). In vitro drug release study revealed that 98.05 ± 0.95 and 93.71 ± 1.05 % of drug was, respectively, released from ACP 19 and PCT 08 formulations at 24 h, whereas only 47.42 ± 0.65 % was released from drug in suspension. ACT 19 and PCT 08, respectively, showed 2.5- and 2.22-folds greater bioavailability than drug in suspension. PK Solver 2.0 was used for analysis of data obtained from in vivo study and the results revealed that both ACP 19 SNEDDS and drug in suspension fit into one-compartment pharmacokinetic model.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Drug Solubulity and Delivery Systems · Advanced Drug Delivery Systems · Surfactants and Colloidal Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (45)
Show source-provided references
1. Ahr HJ, Krause HP, Suwelack D, Weber H (1988) Pharmacokinetics of nisoldipine. II. Distribution to and elimination from tissues and organs following single or repeated administration of [14C] nisoldipine to rats and dogs. Arzneimittelforschung 38:1099–1104
2. Balakumar K, Raghavan CV, Selvan NT, Habibur Rahman SM (2013a) Self emulsifying drug delivery system: optimization and its prototype for various compositions of oils, surfactants and co-surfactants. J Pharm Res 6:510–51410.1016/j.jopr.2013.04.031 ↗
3. Balakumar K, Raghavan CV, Selvan NT, Prasad RH, Abdu S (2013b) Self nanoemulsifying drug delivery system (SNEDDS) of Rosuvastatin calcium: design, formulation, bioavailability and pharmacokinetic evaluation. Colloids Surf, B 112:337–34310.1016/j.colsurfb.2013.08.025 ↗
4. Chakraborty S, Shukla D, Mishra B, Singh S (2009) Lipid—an emerging platform for oral delivery of drugs with poor bioavailability. Eur J Pharm Biopharm 73:1–1510.1016/j.ejpb.2009.06.001 ↗
5. Chavda VP (2012) Are SMEDDS and SNEDDS a same? A gimmick or pharmaceutically relevant. Mintage J Pharm Med Sci 1:7–10
6. Chopra S, Venkatesan N, Betageri GV (2013) Formulation of lipid bearing pellets as a delivery system for poorly soluble drugs. Int J Pharm 446:136–14410.1016/j.ijpharm.2013.02.029 ↗
7. Christiansen ML, Holma R, Kristensen J, Kreilgaard M, Jacobsen J, Abrahamsson B, Müllertz A (2014) Cinnarizine food-effects in beagle dogs can be avoided by administration in a self nano emulsifying drug delivery system (SNEDDS). Eur J Pharm Sci 57:164–17210.1016/j.ejps.2013.11.003 ↗
8. Constantinides PP (1995) Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm Res 12:1561–157210.1023/A:1016268311867 ↗
9. Elgart A, Cherniakov I, Aldouby Y, Domb AJ, Hoffman A (2013) Improved oral bioavailability of BCS class 2 compounds by self nano-emulsifying drug delivery systems (SNEDDS): the underlying mechanisms for amiodarone and talinolol. Pharm Res 30:3029–304410.1007/s11095-013-1063-y ↗
10. Elnaggar YS, El-Massik MA, Abdallah OY (2009) Self-nanoemulsifying drug delivery systems of tamoxifen citrate: design and optimization. Int J Pharm 380:133–14110.1016/j.ijpharm.2009.07.015 ↗
11. Gaur PK, Mishra S, Bajpai M, Mishra A (2014) Enhanced oral bioavailability of efavirenz by solid lipid nanoparticles: in vitro drug release and pharmacokinetics studies. Biomed Res Int. doi: 10.1155/2014/36340410.1155/2014/363404 ↗
12. Gupta S, Chavhan S, Sawant KK (2011) Self-nanoemulsifying drug delivery system for adefovir dipivoxil: design, characterization, in vitro and ex vivo evaluation. Colloids Surf A: Physicochem Eng Asp 392:145–15510.1016/j.colsurfa.2011.09.048 ↗
13. Jeevana JB, Sreelakshmi K (2011) Design and Evaluation of Self-Nanoemulsifying Drug Delivery System of Flutamide. J Young Pharm 3:4–810.4103/0975-1483.76413 ↗
14. Jiang SP, He SN, Li YL et al (2013) Preparation and characteristics of lipid nanoemulsion formulations loaded with doxorubicin. Int J Nanomedicine 8:3141–3150
15. Jinno J-I, Kamada N, Miyake M, Yamada K, Mukai T, Odomi M, Toguchi H, Liversidge GG, Higaki K, Kimura T (2006) Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. J Controlled Release 111:56–6410.1016/j.jconrel.2005.11.013 ↗
16. Kale AA, Patravale VB (2008) Design and evaluation of self-emulsifying drug delivery systems (SEDDS) of nimodipine. AAPS Pharm Sci Tech 9:191–19610.1208/s12249-008-9037-9 ↗
17. Kawakami K (2012) Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs. Adv Drug Deliv Rev 64:480–49510.1016/j.addr.2011.10.009 ↗
18. Kawakami K, Yoshikawa T, Mororo Y, Hayashi T (2002) Microemulsion formulation for enhanced absorption of poorly soluble drugs: I. prescription design. J Control Release 81:65–7410.1016/S0168-3659(02)00049-4 ↗
19. Khan AW, Kotta S, Ansari SH, Sharma RK, Ali J (2012) Potentials and challenges in self-nanoemulsifying drug delivery systems. Exp Opi Drug Deliv 9:1305–131710.1517/17425247.2012.719870 ↗
20. Khoo SM, Humberstone AJ, Porter CJH, Edwards GA, Charman WN (1998) Formulation design and bio availability assessment of lipidic self-emulsifying formulations of halofantrine. Int J Pharm 167:155–16410.1016/S0378-5173(98)00054-4 ↗
21. Kim HJ, Yoon KA, Hahn M, Park ES, Chi SC (2000) Preparation and in vitro evaluation of self-microemulsifying drug delivery systems containing idebenone. Drug Dev Ind Pharm 26:523–52910.1081/DDC-100101263 ↗
22. Kocbek P, Baumgartner S, Kristl J (2006) Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly water-soluble drugs. Int J Pharm 312:179–18610.1016/j.ijpharm.2006.01.008 ↗
23. Liu H, Shang K, Liu W, Leng D, Li R, Kong Y, Zhang T (2014) Improved oral bioavailability of glyburide by a self-nanoemulsifying drug delivery system. J Microencapsul 31:277–28310.3109/02652048.2013.843598 ↗
24. Maghraby GME, Elsergany RN (2014) Fast disintegrating tablets of nisoldipine for intra-oral administration. Pharm Dev Technol 19:641–65010.3109/10837450.2013.813543 ↗
25. Mahmoud EA, Bendas ER, Mohamed MI (2009) Preparation and evaluation of self nanoemulsifying tablets of carvedilol. AAPS Pharm Sci Tech 10:183–19210.1208/s12249-009-9192-7 ↗
26. Mitchell J, Frishman W, Heiman M (1993) Nisoldipine: a new dihydropyridine calcium-channel blocker. J Clin Pharmacol 33:46–5210.1002/j.1552-4604.1993.tb03902.x ↗
27. Nagarsenker MS, Date AA (2007) Design and evaluation of self-nanoemulsifying drug delivery (SNEDDS) for cefpodoxime proxetil. Int J Pharm 329:166–17210.1016/j.ijpharm.2006.08.038 ↗
28. Park MJ, Ren S, Lee BJ (2007) In vitro and in vivo comparative study of itraconazole bioavailability when formulated in highly soluble self-emulsifying system and in solid dispersion. Biopharm Drug Dispos 28:199–20710.1002/bdd.546 ↗
29. Patel J, Patel A, Raval M, Sheth N (2011) Formulation and development of a self-nanoemulsifying drug delivery system of irbesartan. J Adv Pharm Technol Res 2:9–1610.4103/2231-4040.79799 ↗
30. Pouton CW (1997) Formulation of self emulsifying drug delivery system. Adv Drug Del Rev 25:47–5810.1016/S0169-409X(96)00490-5 ↗
31. Pouton CW (2000) Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and "self-microemulsifying" drug delivery systems. Eur J Pharm Sci 11:S93–S9810.1016/S0928-0987(00)00167-6 ↗
32. Pouton CW (2006) Formulation of poorly water soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci 29:278–28710.1016/j.ejps.2006.04.016 ↗
33. Pouton CW (2007) Properties and users of common formulation lipids, surfactants and cosolvents. In: AAPS workshop, www.aapspharmaceutica.com/meetings/files/85/03poultona.pdf
34. Prajapati ST, Joshi HA, Patel CN (2013) Preparation and characterization of self-microemulsifying drug delivery system of olmesartan medoxomil for bioavailability improvement. J Pharm 2013:1–9
35. Safhi MM (2011) Novel spectrophotometric method for the estimation of nisoldipine in bulk and pharmaceutical dosage forms. Der Pharma Chemica 3:275–278
36. Savjani KT, Gajjar AK, Savjani JK (2012) Drug solubility: importance and enhancement techniques. ISRN Pharm. doi: 10.5402/2012/195727
37. Shah RB, Zidan AS, Funck T (2007) Quality by design: characterization of self-nano-emulsified drug delivery systems (SNEDDs) using ultrasonic resonator technology. Int J Pharm 341:189–19410.1016/j.ijpharm.2007.04.009 ↗
38. Shukla JB, Patel SJ (2010) Formulation and evaluation of self micro emulsifying system of candesartan cilexetil. Int J Pharm Pharm Sci 2:143–146
39. Wasan KM (2001) Formulation and physiological and biopharmaceutical issues in the development of oral lipid-based drug delivery systems. Drug Dev Ind Pharm 27:267–27610.1081/DDC-100103726 ↗
40. Wu W, Wang Y, Que L (2006) Enhanced bioavailability of silymarin by selfmicroemulsifying drug delivery system. Eur J Pharm Biopharm 63:288–29410.1016/j.ejpb.2005.12.005 ↗
41. Xiao Y, Lin Z, Liu J, Zhang W, Wang L, Yu P (2012) A transdermal microemulsion-based hydrogel of nisoldipine: preparation, in vitro characterization and in vivo pharmacokinetic evaluation. Asian J Pharm Sci 7:316–328
42. Yamaoka K, Nakagawa T, Uno T (1978) Application of Akaike’s information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm 6:165–17510.1007/BF01117450 ↗
43. Yang R, Huang X, Dou J, Zhai G, Su L (2013) Self-microemulsifying drug delivery system for improved oral bioavailability of oleanolic acid: design and evaluation. Int J Nanomed 8:2917–2926
44. Zhang P, Liu Y, Feng N, Xu J (2008) Preparation and evaluation of self microemulsifiying drug delivery system of oridonin. Int J Pharm 355:269–27610.1016/j.ijpharm.2007.12.026 ↗
45. Zhang H, Zhang FM, Yan SJ (2012) Preparation, in vitro release, and pharmacokinetics in rabbits of lyophilized injection of sorafenib solid lipid nanoparticles. Int J Nanomed 7:2901–291010.2147/IJN.S32415 ↗